Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Currie

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
FASEB Bioadvances|August 25, 2020
An impaired natriuretic peptide hormone system may play a role in COVID-19 severity in vulnerable populationsMark G Currie, Daniel P Zimmer, Perry V Halushka
The American Journal of Gastroenterology|November 8, 2017
Response to Miner et alMark G Currie, Steven J Shiff, Harvey A Schneier, et al.
Journal of Clinical Gastroenterology|March 18, 2021
Differential Bile Acid Detection in Refractory GERD Patient Saliva Using a Simple and Sensitive Liquid Chromatography Tandem Mass Spectrometry ApproachNisha Perez, Kimberly Chambert, Maria Ribadeneira, et al.
American Journal of Therapeutics|September 1, 1995
Nitric Oxide Activates the Cyclooxygenase Pathway in InflammationDaniela Salvemini, Karen Seibert, Jaime L. Masferrer, et al.
Frontiers in Molecular Neuroscience|May 6, 2014
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral painGerhard Hannig, Boris Tchernychev, Caroline B Kurtz, et al.
American Journal of Physiology. Renal Physiology|October 15, 2019
Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failureCourtney M Shea, Gavrielle M Price, Guang Liu, et al.
Neurogastroenterology and Motility|September 30, 2024
FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF<sub>1</sub> agonist mediated visceral hypersensitivity in male ratsMuriel Larauche, Agata Mulak, Chrysanthy Ha, et al.
Arthritis and Rheumatism|July 19, 2002
Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explantsMedora M Hardy, Karen Seibert, Pamela T Manning, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASHKatherine C Hall, Sylvie G Bernier, Sarah Jacobson, et al.
Gastroenterology|January 5, 2010
Efficacy of linaclotide for patients with chronic constipationAnthony J Lembo, Caroline B Kurtz, James E Macdougall, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
FASEB Bioadvances|August 25, 2020
An impaired natriuretic peptide hormone system may play a role in COVID-19 severity in vulnerable populationsMark G Currie, Daniel P Zimmer, Perry V Halushka
The American Journal of Gastroenterology|November 8, 2017
Response to Miner et alMark G Currie, Steven J Shiff, Harvey A Schneier, et al.
Journal of Clinical Gastroenterology|March 18, 2021
Differential Bile Acid Detection in Refractory GERD Patient Saliva Using a Simple and Sensitive Liquid Chromatography Tandem Mass Spectrometry ApproachNisha Perez, Kimberly Chambert, Maria Ribadeneira, et al.
American Journal of Therapeutics|September 1, 1995
Nitric Oxide Activates the Cyclooxygenase Pathway in InflammationDaniela Salvemini, Karen Seibert, Jaime L. Masferrer, et al.
Frontiers in Molecular Neuroscience|May 6, 2014
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral painGerhard Hannig, Boris Tchernychev, Caroline B Kurtz, et al.
American Journal of Physiology. Renal Physiology|October 15, 2019
Soluble guanylate cyclase stimulator praliciguat attenuates inflammation, fibrosis, and end-organ damage in the Dahl model of cardiorenal failureCourtney M Shea, Gavrielle M Price, Guang Liu, et al.
Neurogastroenterology and Motility|September 30, 2024
FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF<sub>1</sub> agonist mediated visceral hypersensitivity in male ratsMuriel Larauche, Agata Mulak, Chrysanthy Ha, et al.
Arthritis and Rheumatism|July 19, 2002
Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explantsMedora M Hardy, Karen Seibert, Pamela T Manning, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASHKatherine C Hall, Sylvie G Bernier, Sarah Jacobson, et al.
Gastroenterology|January 5, 2010
Efficacy of linaclotide for patients with chronic constipationAnthony J Lembo, Caroline B Kurtz, James E Macdougall, et al.
Pageof 5